| Authors: |
Burckart GJ; Office of Clinical Pharmacology, Center for Drug Evaluation and Research, US Food and Drug Administration, Bldg 51 Rm 3184, 10903 New Hampshire Ave, Silver Spring, Maryland, 20903, USA. gilbert.burckart@fda.hhs.gov., Abdel-Rahman S; Office of Clinical Pharmacology, Center for Drug Evaluation and Research, US Food and Drug Administration, Bldg 51 Rm 3184, 10903 New Hampshire Ave, Silver Spring, Maryland, 20903, USA., Choi C; Office of Clinical Pharmacology, Center for Drug Evaluation and Research, US Food and Drug Administration, Bldg 51 Rm 3184, 10903 New Hampshire Ave, Silver Spring, Maryland, 20903, USA., Cober MP; Northeast Ohio Medical University, College of Pharmacy, Rootstown, Ohio, USA., Cummins JE Jr; National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Fotaki N; University of Bath, Bath, UK., Gonzalez D; Schoool of Medicine, Duke University, Durham, North Carolina, USA., Harris D; Merck & Co., Inc, Rahway, New Jersey, USA., Parrott N; Predictive Modeling, Pharmaceutical Sciences, Roche Pharma Research and Early Development, Basel, Switzerland., Patel H; Office of New Drug Products, Office of Pharmaceutical Quality, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA., Wu F; Division of Quantitative Methods and Modeling, Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland, USA., Abend A; Merck & Co., Inc, Rahway, New Jersey, USA. |
